A member asked:

What makes trovax different from other kidney cancer meds (like nexavar, proleukin, torisel, (temsirolimus) sutent)?

A doctor has provided 1 answer

Other drugs worked: Nexavar, torisel, and sutent all received FDA approval because they improved progression free survival. The initial Trovax trial was terminated early because there was little or no prospect of demonstrating a statistically significant survival benefit compared to placebo. http://clincancerres.aacrjournals.org/content/16/22/5539.long

Answered 10/23/2017

880 views

Thank

Related Questions